Shuffle for fans
Chatbot

Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics

Business

Join Zeifmans Partner, Larry Zeifman, and weekly guest thought leaders in the psychedelics space, for a 6 part series, on exploring the business of psychedelics. New episode drops every Wednesday. About Zeifmans: Zeifmans is a full-service tax, accounting and consulting firm based in Toronto,Read more

Popular episodes

Season 2 - Episode 4: Where do we go from here?

May 26 • 20:20

Join out host, Larry Zeifman and this week's guests, Dr. Joseph Tucker, CEO of MagicMed Industries and Kelsey Ramsden, President & CEO of MINDCURE as they discuss the rapid growth of the psychedelic industry, predict future changes within the industry and changes required for psychedelics to become mainstream....

Season 2 - Episode 3: Financing: What investors are looking for and how to stand out

May 19 • 20:20

Join our host, Larry Zeifman and this week's guests, Henry Sant-Cassia, Founding-Partner of The Conscious Fund and Patrick Moher, CEO of Microdose Psychedelic Insights as they discuss Canadian psychedelic companies raising funds, financing for new entrants and why psychedelic companies are sought out by investors.

About Zeifmans...

Season 2 - Episode 2: Regulatory Issues: What's Important

May 12 • 16:30

Join our host, Larry Zeifmanand this week's guests, David Wood, PhD, Partner at BLG and Spencer Hawkswell, CEO of Therapsil - together they discuss CDSA exemptions, Therapsil's work within the psychedelics industry and the future of regulations for psychedelics as medication for mental health treatment.  ...

Season 2 - Episode 1: What's happened since Season 1

May 5 • 19:19

Welcome back to Micro-dosing with Zeifmans - Season 2! Join our host, Larry Zeifman and this week's guests, Doug Drysdale, CEO of Cybin and Josh Bartch, Co-founder, Chairman & CEO of Mydecine Innovation Group, as they provide an industry update from where we left off at the end of season 1. ...

Welcome back to Micro-dosing with Zeifmans!

Apr 28 • 01:27

Welcome back to season 2 of Micro-dosing with Zeifmans:short podcasts on demystifying the business of Psychedelics! Join our host Zeifmans partner, Larry Zeifman, and weekly special guests, for the next 4 weeks as we continue to explore the industry of psychedelics together....

BONUS – Reflecting on key themes and takeaways

Sep 16 • 31:40

On today's bonus episode of Micro-dosing with Zeifmans, our host Larry Zeifman reflects on key themes from our past 6 episodes, with special guests David Wood and Cameron MacDonald, both Partners at BLG and Dr.Joseph Tucker, CEO of MagicMed Industries Inc.. ...

Episode 6: Psychedelics - What could go wrong…stock promoters, mostly prohibited compounds and global interest

Sep 9 • 15:54

On our final episode of Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's notable guest, Bruce Linton, Founder and former Chairman and Chief Executive Officer at Canopy Growth Corporation - together they discuss capital markets, his career, and what's next for the psychedelics industry. ...

Episode 5: Psychedelics 2.0: What will the future hold?

Sep 2 • 23:00

On today's episode of Micro-dosing with Zeifmans, we discuss "what's next" for the psychedelics industry.  Join our host, Larry Zeifman and this week's guests, Ronan Levy, Founder and Executive of Field Trip Health, and Susan Chapelle, Co-CEO of Havn Life, for Episode 5: Psychedelics 2.0....

Episode 4: Cannabis vs Psychedelics: A comparative view with the cannabis industry

Aug 26 • 16:53

On today's episode of Micro-dosing with Zeifmans, we compare the psychedelics industry with the cannabis industry and discuss where the similarities lie and what makes theses industries so vastly different. Join our host, Larry Zeifman and this week's guests, Danny Motyka, CEO of Psygen Labs, Daniel Cohen, CEO of Pharmadrug Inc. and Carl Saling, Founder, CEO and Director o...

Episode 3: “Going Public”: How to prepare and what you need to know

Aug 19 • 17:05

On today's episode of Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's guests, Anna Serin, Director of Listings at The Canadian Securities Exchange ("CSE") and Bill O’Hara, Managing Director, Institutional Equity Sales at Haywood Securities Inc.. Together they discuss what psychedelic companies need to do to prepare to go public, what investors ...

Check out similar podcasts

Oh! What a lovely podcast
The WW1 History Team
iFL TV Boxing Podcast
iFL TV | Podcast.co
Sinisterhood
Cloud10 and iHeartRadio
Arbejdstitel
Oliver Enné & Kristoffer Ernst
TwitterBlogCareersPress KitCommunity GuidelinesTerms of ServicePrivacy Policy
© 2021 Akora Labs, Inc.